North America Precision Diagnostics & Medicine Market: by Type (Molecular Diagnostics, Companion Diagnostics, Genetic Testing, Biomarker Analysis, Liquid Biopsy, Point-of-Care Testing), Application (Oncology, Cardiology, Neurology, Infectious Diseases, Rare Diseases, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Laboratories, Homecare Settings, Pharmacies, Other Distribution Channels), Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In Situ Hybridization, Immunohistochemistry, Other Technologies), Organization Size (Small, Medium, Large) and By North America – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
1. North America Precision Diagnostics & Medicine Market Outlook
2. North America Precision Diagnostics & Medicine Market Executive Summary
2.1. North America Market Revenue Size (USD Million) (2020-2035)
2.2. Key Trends By Segments (2020-2035)
2.3. Key Trends By North America (2020-2035)
3. North America Precision Diagnostics & Medicine Market Key Vendors Analysis
3.1. Precision Diagnostics & Medicine Market Regulatory Framework
3.2. Precision Diagnostics & Medicine Market New Business and Ease of Doing Business Index
3.3. Precision Diagnostics & Medicine Market Recent Developments
3.4. Top Precision Diagnostics & Medicine Market Buyers Details By North America
3.5. Top Precision Diagnostics & Medicine Market Suppliers Details By North America
3.6. Case Studies of Successful Key Ventures
3.7. Top Players Comparative Analysis
3.7.1. Country/Regions
3.8. Key Vendors
3.8.1. Top 5 Precision Diagnostics & Medicine Market Vendors Pricing Analysis
3.8.2. Precision Diagnostics & Medicine Market Product Benchmarking
3.8.3. Precision Diagnostics & Medicine Market Future Investment Plans
3.9. Precision Diagnostics & Medicine Market – Forces
3.9.1. Precision Diagnostics & Medicine Market Drivers
3.9.2. Precision Diagnostics & Medicine Market Restraints
3.9.3. Precision Diagnostics & Medicine Market Challenges
3.9.3.1. Porter's Five Forces Analysis
3.9.3.1.1. Precision Diagnostics & Medicine Market Bargaining Power of Suppliers
3.9.3.1.2. Precision Diagnostics & Medicine Market Bargaining Power of Buyers
3.9.3.1.3. Precision Diagnostics & Medicine Market Threat of New Entrants
3.9.3.1.4. Precision Diagnostics & Medicine Market Threat of Substitutes
3.9.3.1.5. Precision Diagnostics & Medicine Market Degree of Competition
4. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Country Analysis
4.1. North America Precision Diagnostics & Medicine Market Revenue (USD Million) By Country (2020-2035)
5. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Type
5.1. Molecular Diagnostics
5.2. Companion Diagnostics
5.3. Genetic Testing
5.4. Biomarker Analysis
5.5. Liquid Biopsy
5.6. Point-of-Care Testing
6. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Application
6.1. Oncology
6.2. Cardiology
6.3. Neurology
6.4. Infectious Diseases
6.5. Rare Diseases
6.6. Other Applications
7. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Technology
7.1. Next Generation Sequencing (NGS)
7.2. Polymerase Chain Reaction (PCR)
7.3. Microarray
7.4. In Situ Hybridization
7.5. Immunohistochemistry
7.6. Other Technologies
8. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Distribution Channels
8.1. Hospitals
8.2. Diagnostic Centers
8.3. Research Laboratories
8.4. Homecare Settings
8.5. Pharmacies
8.6. Other Distribution Channels
9. North America Precision Diagnostics & Medicine Market Revenue (USD Million) Size (2020-2035)- By Organization Size
9.1. Small
9.2. Medium
9.3. Large
10. Company Profile Analysis
10.1.1. Vendors Overview
10.1.2. Business Portfolio
10.1.3. Geographical Portfolio
10.1.4. Customers
10.1.5. Financial Analysis
11. Sources Covered
11.1. Primary Sources
11.2. Secondary Sources